FindTrial
Sign In

Relationship between valproate levels in blood and its therapeutic effects in patients with Mania

Serum valproate concentrations and therapeutic outcome in patients with bipolar disorder: An observational study in a tertiary care setting.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/10/016232
Enrollment
113
Registered
2018-10-31
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F312- Bipolar disorder, current episodemanic severe with psychotic features

Interventions

None listed

Sponsors

JIPMER Intramural fund
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Manic phase of Bipolar disorder Recieving sodium valproate

Exclusion criteria

Exclusion criteria: Recieving concomitant Lithium and Carbamazepine therapy, Substance abuse, organic mood disorder, seizure disorder

Design outcomes

Primary

MeasureTime frame
Clinical outcome measured with Young Mania Rating Scale scoreTimepoint: During admission period—

Secondary

MeasureTime frame
Adverse effectsTimepoint: During admission period—

Countries

India

Contacts

Public ContactDr Ravi Philip RajKumar

JIPMER Pondicherry

drsmanikandan001@gmail.com9443774648

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026